EVO ICL vs LASIK: 2026 Comparison Guide

LASIK vs. EVO ICL: Which Vision Correction Procedure Is Right for You?

Two Advanced Vision Correction Procedures — Personalized for Your Eyes

Both LASIK and EVO ICL™ can provide life-changing freedom from glasses and contact lenses, but they work in very different ways and are designed for different types of patients. Understanding the differences between LASIK and EVO ICL is essential when choosing the best long-term vision correction solution for your eyes and lifestyle.

LASIK uses advanced laser technology to reshape the cornea and improve how light focuses on the retina. EVO ICL, also known as the EVO Implantable Collamer® Lens, corrects vision by placing a soft, biocompatible Collamer lens inside the eye without removing corneal tissue. Because EVO ICL preserves the natural shape of the cornea, it is often an excellent option for patients with thin corneas, dry eyes, high prescriptions, or those who may not be ideal LASIK candidates.

The best procedure depends on several important factors, including:

• Prescription strength
• Corneal thickness and shape
• Dry eye history
• Age and lifestyle
• Night vision quality
• Long-term visual goals

Why Choose California Center for Refractive Surgery (CCRS)?

One of the biggest differences at California Center for Refractive Surgery (CCRS) is that patients receive truly unbiased recommendations. Many vision correction centers specialize primarily in LASIK and naturally recommend the procedure they perform most often. At CCRS, Dr. Paul C. Lee specializes in all major forms of advanced vision correction surgery, including LASIK, SMILE, EVO ICL, refractive lens exchange (RLE), and cataract surgery. This comprehensive expertise allows him to recommend the procedure that is genuinely best for each patient’s eyes rather than a one-size-fits-all approach.

Dr. Lee is recognized as one of the leading experts in refractive surgery in the greater Los Angeles area. He is the only surgeon in the region to have performed more than 2,000 EVO ICL procedures and was also the first surgeon in Los Angeles to introduce the advanced VisuMax®–WaveLight EX500 all-laser LASIK platform. Today, this technology is considered one of the gold standards in modern laser vision correction, known for exceptional precision, customization, and visual outcomes.

With more than 25 years of experience and over 50,000 vision correction procedures performed, Dr. Lee combines extensive surgical expertise with a highly personalized approach to patient care. Every patient at CCRS is personally evaluated by Dr. Lee, and every diagnostic measurement and imaging study is carefully reviewed before surgery is recommended or performed. This individualized approach helps ensure the highest level of safety, accuracy, and long-term visual quality for each patient.

Below, you’ll find our comprehensive 2026 guide comparing EVO ICL and LASIK, including the key differences between the procedures, ideal candidate profiles, advantages and limitations of each option, and what patients can expect throughout the entire vision correction journey — from consultation and surgery to recovery and long-term visual outcomes. 

At-a-Glance

The 60-Second LASIK vs. EVO ICL Comparison

Both LASIK and EVO ICL are advanced vision correction procedures capable of delivering exceptional, glasses-free vision with long-standing records of safety, precision, and patient satisfaction. While both procedures can achieve 20/20 vision or better in the vast majority of appropriately selected patients, they correct vision in very different ways.

LASIK

LASIK reshapes the cornea using advanced femtosecond and excimer laser technology to improve how light focuses on the retina. The procedure is fast, highly effective, and often ideal for patients with low-to-moderate nearsightedness, farsightedness, and astigmatism who have healthy corneas and minimal dry eye symptoms.

EVO ICL

EVO ICL (Implantable Collamer® Lens) corrects vision by implanting a soft biocompatible lens behind the iris and in front of the eye’s natural lens. Unlike LASIK, EVO ICL does not remove corneal tissue and is fully removable if needed in the future. EVO ICL is an excellent option for a wide range of prescriptions and is especially beneficial for patients with moderate-to-high myopia, thin corneas, chronic dry eye, or patients who are not ideal LASIK candidates.

Which Procedure Is Better for You?

• Patients with high myopia, thin corneas, or dry eye symptoms are often better candidates for EVO ICL.
• Patients with low-to-moderate myopia or hyperopia and healthy corneas may benefit from LASIK’s faster recovery and lower overall procedural cost.

Both procedures have been extensively studied and have demonstrated excellent long-term safety and visual outcomes over decades of clinical use. The best choice ultimately depends on your eye anatomy, prescription, lifestyle, and long-term vision goals.

How They Work

LASIK vs. EVO ICL: The Procedures Side-by-Side

LASIK: Reshaping the Cornea

LASIK (Laser-Assisted In Situ Keratomileusis) is an advanced laser vision correction procedure that reshapes the cornea to improve how light focuses on the retina. During the procedure, a femtosecond laser creates an ultra-thin hinged flap on the surface of the cornea. An excimer laser then precisely reshapes the underlying corneal tissue at the micron level to correct nearsightedness, farsightedness, and astigmatism. Once the treatment is completed, the flap is repositioned and naturally adheres within minutes without stitches. The laser treatment itself typically takes only about 10–15 minutes for both eyes.

At California Center for Refractive Surgery (CCRS), Dr. Paul C. Lee offers both Wavefront-guided and Contoura® Vision topography-guided LASIK technologies for highly customized vision correction. Contoura Vision uses sophisticated corneal topography imaging to generate a detailed three-dimensional map of the corneal surface, allowing treatment to be tailored to the unique shape and optical imperfections of each individual eye.

Clinical studies evaluating topography-guided LASIK have demonstrated exceptional visual outcomes, with approximately 91.8% to 97% of patients achieving 20/20 vision or better, and many patients achieving 20/15 vision or sharper following surgery.

EVO ICL: Adding a Lens Inside the Eye

EVO ICL (Implantable Collamer® Lens) is an advanced vision correction procedure often described as an “implantable contact lens.” Unlike LASIK, EVO ICL corrects vision without removing corneal tissue. During the procedure, a thin, flexible lens made from biocompatible Collamer® material is inserted through a tiny corneal incision measuring approximately 2.5 mm. The lens is carefully positioned behind the iris and in front of the eye’s natural lens, where it works with the eye’s natural optical system to precisely focus light onto the retina.

Collamer® is a proprietary material composed of purified collagen and advanced polymer technology designed for long-term biocompatibility, optical clarity, flexibility, and stability inside the eye. Because the cornea remains largely untouched, EVO ICL is an excellent option for patients with thin corneas, chronic dry eye, high myopia, or patients seeking a reversible vision correction solution.

The EVO ICL procedure typically takes approximately 20–30 minutes for both eyes and offers rapid visual recovery with exceptional visual quality and contrast sensitivity.

Dr. Paul C. Lee has been an early adopter of EVO ICL technology since its introduction in the United States in 2005 and was recognized as the Top ICL Surgeon in the Nation in 2014. He is also the only surgeon in California to have surpassed the milestone of more than 2,000 ICL implantation procedures, reflecting extensive experience with advanced implantable lens technology and complex refractive correction cases.

Because Dr. Lee performs both LASIK and EVO ICL at a high level and high surgical volume, patients at California Center for Refractive Surgery (CCRS) receive truly personalized and unbiased recommendations based on their eye anatomy, prescription, lifestyle, and long-term vision goals — rather than being directed toward a single procedure simply because it is the primary service offered by the practice. His comprehensive expertise in all major forms of refractive surgery allows patients to confidently choose the procedure that is genuinely best suited for their eyes.

Direct Comparison

2026 Head-to-Head Comparison Table

Candidacy

Who Is the Better Candidate for Each Procedure?

Neither LASIK nor EVO ICL is universally “better” — each procedure is designed for different types of eyes and different visual needs. The ideal choice depends on your prescription, corneal anatomy, ocular health, lifestyle, and long-term vision goals.

In general, the primary limitations for LASIK relate to the health and structural characteristics of the cornea. Patients with thin corneas, irregular corneal shape, keratoconus, significant dry eye disease, or very high prescriptions may not be ideal LASIK candidates because the procedure requires permanent removal of corneal tissue to reshape the eye.

EVO ICL, on the other hand, does not remove corneal tissue and is often an excellent option for patients with moderate-to-high myopia, thin corneas, or chronic dry eye symptoms. However, EVO ICL requires sufficient anatomical space inside the eye to safely position the implantable lens between the iris and the natural crystalline lens. Patients with shallow anterior chamber depth or certain anatomical limitations may not qualify for EVO ICL surgery.

Patients Often Better Suited for LASIK

• Low-to-moderate myopia
• Hyperopia (farsightedness)
• Mild-to-moderate astigmatism
• Healthy corneal thickness and shape
• Minimal dry eye symptoms
• Patients seeking rapid visual recovery and lower procedural cost

Patients Often Better Suited for EVO ICL

• Moderate-to-high myopia
• Thin corneas
• Chronic dry eye symptoms
• Patients seeking a reversible procedure
• Patients who are not ideal LASIK candidates
• Patients desiring preservation of corneal tissue and natural corneal biomechanics

A comprehensive vision evaluation is essential to determine which procedure is safest and most likely to provide the highest quality long-term visual outcome.

Recovery

Recovery & Visual Results

Both procedures have remarkably fast recovery, but the timelines differ slightly:

LASIK Recovery

• Day 1: Most patients see clearly enough to drive and return to work
• Week 1: Normal activities resume; no rubbing or swimming
• Month 1–3: Vision continues to sharpen; dry eye gradually resolves, glare and halos improve or disappear.

EVO ICL Recovery

• Day 1: Clear vision for most patients, often 20/20 the next morning
• Week 1: Most activities resume; avoid eye trauma
• Week 6–8: Halos and night-vision symptoms continue to improve

Cost & Value

How Much Do LASIK and EVO ICL Cost in 2026?

The cost of LASIK and EVO ICL in 2026 can vary depending on several factors, including surgeon experience, technology used, geographic location, prescription complexity, and whether the procedure is performed in a hospital or office-based surgical facility.

At California Center for Refractive Surgery (CCRS), patients benefit from highly competitive pricing combined with advanced technology, extensive surgical expertise, and a transparent pricing model backed by our Price Guarantee. One of the reasons CCRS is able to offer exceptional value is because Dr. Paul C. Lee is one of the highest-volume EVO ICL surgeons in the Los Angeles area, and CCRS has invested in a state-of-the-art in-office surgical suite specifically designed for advanced refractive procedures, including EVO ICL surgery.

Many practices perform EVO ICL procedures at outside ambulatory surgery centers or hospitals, which can add thousands of dollars in separate facility and anesthesia fees. By performing surgery in our advanced office-based surgical center, CCRS is able to reduce overhead costs and pass those savings directly on to patients without compromising safety, technology, or quality of care.

CCRS 2026 Pricing with Price Guarantee

• LASIK: Approximately $2,000 per eye
  (All-inclusive pricing comparable to many premium LASIK practices)
• EVO ICL: Approximately $3,000–$4,500 per eye
  (Pricing varies depending on prescription strength and presence of astigmatism)

Financing and Payment Options

Both LASIK and EVO ICL are eligible for:

• Health Savings Accounts (HSA)
• Flexible Spending Accounts (FSA)
• Monthly financing plans, including 0% financing options for qualified patients

Long-Term Value of Vision Correction

While refractive surgery is often viewed as an elective investment, many patients are surprised to learn that the long-term cost of contact lenses, cleaning solutions, prescription glasses, sunglasses, eye exams, and replacement eyewear frequently exceeds $12,000 over time. For many individuals, LASIK or EVO ICL may effectively pay for itself within approximately 5–8 years while also providing greater convenience, freedom, and quality of life.

Honest Trade-offs

Pros and Cons of LASIK vs. EVO ICL

Both LASIK and EVO ICL are highly advanced vision correction procedures with excellent long-term safety records and high patient satisfaction rates. However, each procedure has unique advantages and limitations, and the best choice depends on your eye anatomy, prescription, lifestyle, and long-term visual goals.

Advantages of LASIK

• Fast procedure and rapid visual recovery
   Most patients notice dramatically improved vision within 24 hours and return to normal activities quickly.
• Extensive long-term track record
   LASIK has nearly 30 years of clinical data and more than 40 million procedures performed worldwide, making it one of the most studied elective procedures in medicine.
• Lower upfront cost compared to EVO ICL
   LASIK is generally more affordable while still providing excellent visual outcomes for appropriate candidates.
• Treats multiple refractive errors
   LASIK can effectively correct:
  • Nearsightedness (myopia)
  • Farsightedness (hyperopia)
  • Astigmatism
• Advanced customization options
   Modern technologies such as Wavefront-guided and Contoura® topography-guided LASIK provide highly personalized treatment and exceptional visual precision.

Limitations of LASIK

• Permanent corneal reshaping
   LASIK permanently removes corneal tissue and cannot be reversed.
• Not ideal for all corneas or prescriptions
   Patients with thin corneas, irregular corneas, keratoconus, or very high prescriptions may not be ideal candidates.
• Potential increase in dry eye symptoms
   Some patients experience temporary or persistent dry eye symptoms following surgery.
• May limit some future corneal treatment options
   Because tissue is removed from the cornea, certain future procedures may be more limited depending on corneal thickness and stability.

EVO ICL: Pros and Cons

Advantages of EVO ICL

• Reversible procedure
   The EVO Implantable Collamer® Lens can be removed or exchanged if necessary in the future.
• Excellent for moderate-to-high myopia
   EVO ICL is particularly beneficial for patients with stronger prescriptions that may exceed ideal LASIK treatment ranges.
• Ideal for thin corneas and dry eye patients
   Because no corneal tissue is removed, EVO ICL preserves the natural structure and biomechanics of the cornea.
• Exceptional visual quality
   Many patients report outstanding sharpness, contrast sensitivity, and night vision quality following EVO ICL surgery.
• Preserves future surgical options
   Since the cornea remains largely untouched, patients may maintain more long-term refractive and corneal treatment options.

Limitations of EVO ICL

• Higher upfront cost than LASIK
   EVO ICL is generally more expensive due to the implantable lens technology and surgical complexity.
• Does not currently treat farsightedness in the United States
   EVO ICL is FDA-approved primarily for the treatment of myopia and myopic astigmatism.
• Intraocular procedure
   Some patients are less comfortable with the concept of placing a lens inside the eye, even though EVO ICL has demonstrated excellent long-term safety and biocompatibility.

Ultimately, both LASIK and EVO ICL can provide life-changing freedom from glasses and contact lenses. A comprehensive consultation with Dr. Paul C. Lee at California Center for Refractive Surgery (CCRS) can help determine which procedure offers the safest and highest-quality long-term visual outcome for your individual eyes.

Experience & Expertise

Why Choose California Center for Refractive Surgery (CCRS) for LASIK and EVO ICL?

Most refractive surgery practices focus heavily on a single procedure and naturally recommend that option to nearly every patient. At California Center for Refractive Surgery (CCRS), patients benefit from a truly comprehensive and personalized approach to modern vision correction.

Dr. Paul C. Lee performs both LASIK and EVO ICL at a high surgical volume using the latest 2026 vision correction technologies. Because CCRS specializes in multiple advanced refractive procedures — including LASIK, EVO ICL, SMILE, refractive lens exchange (RLE), and cataract surgery — recommendations are based on what is genuinely safest and best for the patient’s eyes rather than on the limited offerings of a single-procedure practice.

CCRS has helped thousands of patients throughout Los Angeles, Pasadena, the San Fernando Valley, Rosemead, Arcadia, Sherman Oaks, and surrounding Southern California communities achieve life-changing visual freedom with customized refractive surgery solutions.

What Sets CCRS Apart

• Comprehensive Expertise in Both LASIK and EVO ICL
   Dr. Lee is one of the few refractive surgeons in the region with extensive high-volume experience in both advanced laser vision correction and implantable lens surgery.
• Over 25 Years of Refractive Surgery Experience
   With more than 50,000 vision correction procedures performed, CCRS combines experience, precision, and advanced technology to optimize patient outcomes.
• One of California’s Most Experienced EVO ICL Surgeons
   Dr. Lee was an early adopter of EVO ICL technology and is the only surgeon in California to have surpassed the milestone of more than 2,000 ICL implantation procedures.
• Advanced LASIK Technology
   CCRS utilizes state-of-the-art femtosecond and excimer laser platforms, including Wavefront-guided and Contoura® topography-guided LASIK for highly customized treatment.
• Personalized Surgical Planning
   Every patient is personally evaluated by Dr. Lee, and every diagnostic scan, corneal map, and refractive measurement is individually reviewed before surgery is recommended or performed.
• Office-Based Surgical Excellence
   CCRS features a state-of-the-art in-office surgical suite designed specifically for advanced refractive procedures, helping provide exceptional safety, efficiency, convenience, and value.
• Transparent Pricing and Financing Options
   CCRS offers competitive pricing, a Price Guarantee, and financing options including HSA/FSA eligibility and 0% financing for qualified patients.
• Commitment to Long-Term Vision Quality
   Rather than focusing solely on short-term visual acuity, CCRS emphasizes long-term visual performance, corneal health, optical quality, and preservation of future treatment options.

Whether you are considering LASIK or EVO ICL, CCRS provides the expertise, technology, and individualized care necessary to help you achieve the highest quality vision possible for years to come.

Frequently Asked Questions About LASIK vs. EVO ICL

Is EVO ICL better than LASIK?

Neither procedure is universally “better” — they are designed for different types of eyes and different visual needs. EVO ICL often provides significant advantages for patients with moderate-to-high myopia, thin corneas, or chronic dry eye symptoms because it does not remove corneal tissue. LASIK is commonly an excellent option for patients with low-to-moderate prescriptions and healthy corneas due to its rapid recovery, lower cost, and extensive long-term track record.

At California Center for Refractive Surgery (CCRS), Dr. Paul C. Lee performs both LASIK and EVO ICL at a high level and high surgical volume, allowing patients to receive a genuinely personalized and unbiased recommendation based on their unique eye anatomy and long-term vision goals.

Is EVO ICL really reversible?

Yes. One of the unique advantages of EVO ICL is that the Implantable Collamer® Lens can be removed or exchanged if necessary in the future. While EVO ICL is designed as a long-term vision correction solution, reversibility provides flexibility if a patient’s prescription changes significantly later in life or if additional treatment becomes desirable.

Which procedure has a faster recovery — LASIK or EVO ICL?

Both LASIK and EVO ICL typically offer rapid visual recovery. Most patients are able to drive and return to work within one day after surgery. Visual recovery experiences can vary slightly depending on the individual patient and prescription, but both procedures are designed to minimize downtime.

CCRS provides comprehensive postoperative care and multiple follow-up visits as part of one transparent, all-inclusive surgical fee.

Can I get EVO ICL if I’m over 45?

Yes. However, patients over the age of 45 may also benefit from discussing Refractive Lens Exchange (RLE), an advanced lens replacement procedure that can simultaneously address distance vision, near vision, and age-related presbyopia while also preventing future cataract development.

Will I still need reading glasses after LASIK or EVO ICL?

Both LASIK and EVO ICL are highly effective at correcting distance vision. However, beginning commonly in the mid-40s, most people naturally develop presbyopia — an age-related loss of near focusing ability. Presbyopia occurs independently of LASIK or EVO ICL and may eventually require reading glasses or additional vision correction strategies for near tasks.

Can I get EVO ICL if I was told I’m not a LASIK candidate?

Often, yes. Many patients who are not ideal LASIK candidates because of thin corneas, very high prescriptions, irregular corneal shape, or chronic dry eye may still be excellent candidates for EVO ICL. A comprehensive consultation with a surgeon experienced in both procedures is the best way to determine the safest and most effective option for your eyes.

How long do LASIK and EVO ICL last?

Both LASIK and EVO ICL are considered forms of permanent vision correction. In LASIK, the corneal reshaping is permanent. In EVO ICL, the Collamer® lens material has demonstrated more than 30 years of long-term biocompatibility and stability inside the eye.Although the original correction itself does not “wear off,” natural age-related eye changes — such as presbyopia or cataract formation — may eventually require additional treatment later in life.

The Bottom Line: Which Procedure Is Right for You?

There is no single universal “winner” between LASIK and EVO ICL — only the procedure that is best suited for your specific eyes, prescription, lifestyle, and long-term vision goals.

At California Center for Refractive Surgery (CCRS), patients benefit from a truly individualized approach to vision correction. Dr. Paul C. Lee personally reviews every diagnostic scan and evaluates every patient to determine which procedure is most likely to provide the safest treatment, highest visual quality, and best long-term outcome — rather than relying on a one-size-fits-all recommendation. Contact us today to schedule your personalized consultation with Dr. Lee.

Peer-Reviewed References

1. Moshirfar M, Shah TJ, Skanchy DF, Linn SH, Durrie DS. Comparison and analysis of FDA-reported visual outcomes of the three latest platforms for LASIK. Clinical Ophthalmology. 2017;11:2217-2228. doi:10.2147/OPTH.S143637
2. Kanellopoulos AJ. Topography-guided LASIK versus small incision lenticule extraction (SMILE) for myopia and myopic astigmatism. Journal of Refractive Surgery. 2017;33(6):375-380. doi:10.3928/1081597X-20170413-02
3. Brown DC, Grabow HB, Martin RG, et al. Collamer intraocular lens: clinical results from the U.S. FDA study. Journal of Cataract & Refractive Surgery. 2001;27(11):1837-1847.
4. Packer M. The implantable collamer lens with a central port: review of the literature. Clinical Ophthalmology. 2018;12:2427-2438. doi:10.2147/OPTH.S188785.
5. Parkhurst GD, Packer M, Dougherty PJ, et al. Three-year results from the United States FDA prospective clinical trial of the EVO/EVO+ Visian Implantable Collamer Lens. Clinical Ophthalmology. 2025;19:2501-2514.